Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,172 | 79,506 | 168,770 | 138,780 | 353,069 |
| Marketable Securities | 438,313 | 446,729 | 402,290 | 376,622 | 232,045 |
| Receivables | 43,549 | 52,749 | 104,159 | 133,303 | 160,261 |
| Other current assets | 32,689 | 48,889 | 21,395 | 26,480 | 19,958 |
| TOTAL | $580,723 | $627,873 | $696,614 | $675,185 | $765,333 |
| Non-Current Assets | |||||
| PPE Net | 79,083 | 81,353 | 81,807 | 86,049 | 68,622 |
| Investments And Advances | 366,833 | 326,648 | 346,946 | 415,621 | 493,182 |
| Intangibles | 291,819 | 293,670 | 208,166 | 211,049 | 86,036 |
| Other Non-Current Assets | 58,309 | 56,509 | 72,249 | 73,758 | 52,417 |
| TOTAL | $796,044 | $758,180 | $709,168 | $786,477 | $700,257 |
| Total Assets | $1,376,767 | $1,386,053 | $1,405,782 | $1,461,662 | $1,465,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,999 | 14,999 | 14,999 | 14,999 | 14,999 |
| Accounts payable and accrued liabilities | 22,080 | 23,093 | 14,481 | 37,109 | 23,699 |
| Accrued Expenses | 21,088 | 24,981 | 25,101 | 27,100 | 11,847 |
| Other current liabilities | 18,164 | 19,395 | 42,034 | 39,722 | 32,920 |
| TOTAL | $81,939 | $88,107 | $102,522 | $127,527 | $141,714 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 26,418 | 28,315 | 22,239 | 23,840 | 11,338 |
| TOTAL | $25,909 | $28,071 | $21,863 | $23,402 | $10,916 |
| Total Liabilities | $107,848 | $116,178 | $124,385 | $150,929 | $152,630 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,701 | 29,519 | 29,438 | 30,266 | 30,327 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 785,660 | 801,000 | 824,832 | 823,113 | 811,576 |
| Other shareholders' equity | -12,725 | -17,713 | -21,252 | -16,449 | -5,665 |
| TOTAL | $1,268,919 | $1,269,875 | $1,281,397 | $1,310,733 | $1,312,960 |
| Total Liabilities And Equity | $1,376,767 | $1,386,053 | $1,405,782 | $1,461,662 | $1,465,590 |